INmune Bio (INMB) Stock Chart & Stock Price History $2.35 +0.05 (+1.96%) As of 11:40 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INmune Bio Stock Price Performance The INmune Bio (INMB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 69.51%, with a year-to-date return of -49.79%. In the past month, the stock has decreased 69.23%, reflecting recent market activity. As of the latest close, INmune Bio traded at $2.30 with a market cap of $54.23 million and volume of 3.28 million shares. Five years ago, the stock traded at $4.92, representing a 52.34% decrease over that period. At the time, it had a market cap of $55.94 million and a volume of 21,900 shares. Receive INMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-9.98%1 Month Performance-69.23%3 Month Performance-65.72%Year-To-Date Performance-49.79%1 Year Performance-69.51%5 Year Performance-52.34% INMB Stock Chart for Tuesday, July, 8, 2025 INMB Chart by TradingView INmune Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/07/2025$2.61$2.30-11.71%$2.50$2.243.28 million shs$54.23 million07/04/2025$2.61$2.61$2.77$2.304.70 million shs$61.43 million07/03/2025$2.36$2.61+10.38%$2.77$2.304.70 million shs$61.44 million07/02/2025$2.09$2.36+12.92%$2.43$2.045.86 million shs$54.23 million07/01/2025$2.31$2.09-9.52%$2.22$1.898.75 million shs$48.03 million06/30/2025$5.33$2.31-56.66%$2.34$2.0032.68 million shs$53.08 million06/27/2025$6.28$5.33-15.13%$11.64$5.0159.45 million shs$122.48 million06/26/2025$7.37$6.28-14.79%$7.64$6.113.54 million shs$144.31 million06/25/2025$6.61$7.37+11.50%$7.40$6.61920,670 shs$169.36 million06/24/2025$6.22$6.61+6.27%$6.97$6.36974,573 shs$151.92 million Get the Latest News and Ratings for INMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. 06/23/2025$6.38$6.22-2.51%$6.58$5.602.10 million shs$142.94 million06/20/2025$7.24$6.38-11.88%$7.49$6.161.49 million shs$146.61 million06/19/2025$7.24$7.24$7.47$6.811.00 million shs$166.40 million06/18/2025$6.87$7.24+5.39%$7.47$6.811.00 million shs$166.38 million06/17/2025$8.02$6.87-14.34%$8.04$6.681.74 million shs$157.90 million06/16/2025$7.70$8.02+4.16%$8.05$7.60670,791 shs$184.33 million06/13/2025$7.92$7.70-2.78%$8.01$7.65593,330 shs$176.98 million06/12/2025$8.09$7.92-2.10%$8.21$7.47649,681 shs$182.03 million06/11/2025$7.88$8.09+2.66%$8.29$7.81784,942 shs$185.94 million06/10/2025$7.65$7.88+3.01%$8.28$7.78855,014 shs$181.11 million06/09/2025$7.62$7.65+0.39%$8.09$7.57887,145 shs$175.83 million Related Companies Cardiff Oncology Stock Chart MediWound Stock Chart Eupraxia Pharmaceuticals Stock Chart SOPHiA GENETICS Stock Chart Inhibrx Biosciences Stock Chart Y-mAbs Therapeutics Stock Chart AC Immune Stock Chart Vor Biopharma Stock Chart scPharmaceuticals Stock Chart I-Mab Stock Chart Receive INMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INMB) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredNobel Prize Material Finally Goes CommercialA Nobel Prize–winning material just got its biggest breakthrough in 30 years. A little-known company has cr...True Market Insiders | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INmune Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INmune Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INMB Stock Alerts